Gnosis by Lesaffre presented a post-hoc analysis examining SAMe’s effects on cognitive function and sleep health in postmenopausal women at the Nutrients 2026 Conference, sparking constructive dialogue within the scientific community.
Addressing cognitive challenges in postmenopausal women
The recent 2nd edition of the Nutrients 2026 Conference – Clinical Nutrition: From Research to Practice in Barcelona provided a valuable opportunity to share new insights into Adonat® SAMe research and engage with an audience primarily composed of academic researchers, nutritionists, dietitians, and healthcare professionals.
Organized by Nutrients, the peer-reviewed international journal published by MDPI, the conference brought together researchers and healthcare professionals from the international scientific community to discuss the latest advances in nutrition and clinical research. The event provided a platform for sharing scientific findings and fostering exchange on emerging developments in the field.
During the poster session, Chiara Cecconello, Science Lead at Gnosis by Lesaffre, presented a post-hoc analysis involving 126 postmenopausal women. The study examined SAMe’s effects on cognitive function, sleep-related impairment, and fatigue compared with placebo over six weeks of treatment at 400 mg daily. The presentation generated positive interest among attendees, with particular attention to the sample size and observed effects compared with placebo, which were highlighted as encouraging findings given the challenges of demonstrating significant effects in this population.
Significant improvements across multiple health domains
The post-hoc analysis revealed
- Statistically significant improvements in cognitive function compared with placebo (p = 0.016).
- Sleep-related impairment improved significantly versus placebo (p = 0.007) and baseline.
- Fatigue showed a significant improvement from baseline (p = 0.001), with a favorable trend compared with placebo.
Conference attendees highlighted these results as encouraging, noting that improvements in cognitive function, sleep quality, and fatigue suggest interconnected benefits that merit deeper scientific exploration in postmenopausal women.
Significant MyCondro™ findings recognized by the scientific program
In addition to sharing insights from the Adonat® study during the poster session, Gnosis contributed to the scientific program with an oral presentation on MyCondro™, our fermentation-derived chondroitin sulfate.
The research, entitled “The effect of fermentation-derived chondroitin sulfate in mild to moderate knee osteoarthritis symptoms management,” also presented by Cecconello, received the Best Oral Presentation Award.
This recognition further highlights Gnosis by Lesaffre’s commitment to advancing scientific research and exploring innovative fermentation-based solutions for mobility and joint health.
Adonat® new brand evolution reflects a continued commitment to raise human health
The Adonat® post-hoc analysis comes shortly after the launch of its refreshed brand identity, offering another opportunity to highlight Gnosis’ scientific commitment and its ambition to “Think like Nature, to raise the standard of human health”.
Deep Dive Into SAMe
Research studies over the past five decades have unequivocally established the importance of S-adenosyl-L-methionine (SAMe). An endogenously produced compound that plays a critical role in cellular metabolism and function, SAMe is second only to ATP as the most important molecule in cell biology.